首页 快讯正文

ios developer account:US, India, Australia, Japan agree to send 1 billion vaccines across Asia by end-2022

admin 快讯 2021-03-30 05:01:12 60 0

USDT自动充值

菜宝钱包(caibao.it)是使用TRC-20协议的Usdt第三方支付平台,Usdt收款平台、Usdt自动充提平台、usdt跑分平台。免费提供入金通道、Usdt钱包支付接口、Usdt自动充值接口、Usdt无需实名寄售回收。菜宝Usdt钱包一键生成Usdt钱包、一键调用API接口、一键无实名出售Usdt。

choi Baccarat

sàn casino đổi thưởng tiền mặt uy tín SỐ 1 ,Bạn có thể nạp và rút tiền với; Ví điện tử ; đồng tiền ảo; usdt; an toàn tiện lợi và có độ bảo mật cao. Mọi thông tin chi tiết xin liên hệ URL:www.vng.app。

,NEW DELHI - Leaders of the United States, India, Australia and Japan agreed to pool financing, manufacturing and distribution capacity to send 1 billion coronavirus vaccines across Asia by the end of 2022, India's foreign secretary said on Friday. The so-called "Quad" group of four nations want to expand global vaccinations and counter China's growing vaccination diplomacy in Southeast Asia and around the world. India is the world's biggest vaccine maker. The collaboration was "most pressing and valuable", foreign secretary Harsh Vardhan Shringla told a news conference in India's capital New Delhi after the four-way virtual summit. "The four countries have agreed to a plan to pool their financial resources, manufacturing capabilities and capacities, and logistical strengths so as to ramp up the manufacturing and distribution of the COVID-19 vaccines in the Indo-Pacific region," he said. "We believe this will speed up the process of post-pandemic recovery and enable families and businesses to put the COVID-19 crisis behind them." India will use its manufacturing capacity to make U.S. vaccines, with financing coming from the U.S. International Development Finance Corporation and the Japan Bank for International Cooperation. Australia will finance training and provide last-mile logistical support for the distribution of vaccines, he added, that will predominantly go to the Pacific Islands, Southeast Asia and countries in the Indian Ocean. The initiative, however, may be hampered by U.S. export restrictions on critical raw materials for India's vaccine supply chain. Shringla said the issue is a bilateral one with the United States that has been raised by India's ambassador in Washington. "Consideration is being given to this very important point," he said, without elaborating. The tie-up will not impact the production of vaccines for India's 1.4 billion people, Shringla added. REUTERS
转载说明:本文转载自Sunbet。
版权声明

本文仅代表作者观点,
不代表本站通辽信息网的立场。
本文系作者授权发表,未经许可,不得转载。

发表评论

评论列表(0人评论 , 60人围观)
☹还没有评论,来说两句吧...

站点信息

  • 文章总数:3052
  • 页面总数:0
  • 分类总数:8
  • 标签总数:2932
  • 评论总数:1470
  • 浏览总数:718589